Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: Implementation of a program of highly active antiretroviral therapy in a resource-poor setting

Pediatric Infectious Disease Journal

Volumn 23, Issue 8, 2004, Pages 695-700

  Kline, Mark W ^a   Matusa, Rodica F ^b   Copaciu, Letitia ^b   Calles, Nancy R ^b   Kline, Nancy E ^b   Schwarzwald, Heidi L ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Antiretroviral therapy; Human immunodeficiency virus infection; Infant or child; Romania

Indexed keywords

ANTIRETROVIRUS AGENT; LOPINAVIR; PROTEINASE INHIBITOR;

BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; GOVERNMENT; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PEDIATRICS; PNEUMOCYSTIS PNEUMONIA; POVERTY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; ROMANIA; T LYMPHOCYTE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD DEVELOPMENT; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PRIMARY HEALTH CARE; PROGRAM DEVELOPMENT; ROMANIA; SPECIALTIES, MEDICAL; TREATMENT OUTCOME;

EID: 4043099632     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000135454.46188.83     Document Type: Review

References (13)

1. Romanian Ministry of Health and Family. HIV/AIDS update. FORUM Newsl. 2002;8.
2. World Health Organization. Available at: http://www.who.int/country. Accessed February 10, 2004.
3. Novotny T, Haazen D, Adeyi O. HIV/AIDS in southeastern Europe: case studies from Bulgaria, Croatia and Romania. The World Bank, Washington, DC, February 11, 2003.
4. Kline MW, Matusa RF, Simon CL, Kline NE. Four-year longitudinal study of HIV among children in Constanta, Romania. Presented at the 40th Annual Meeting of the Infectious Diseases Society of America [abstr. 438], Chicago, 2002.
5. Kozinetz CA, Matua R, Cazacu A. The burden of pediatric HIV/AIDS in Constanpa, Romania: a cross-sectional study. BMC Infect Dis. 2001; 1:7.
6. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43(RR-12):1-10.
7. Centers for Disease Control and Prevention. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR. 1995;44(RR-4):1-11.
8. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979;32:607-629.
9. Roche AF, Himes JH. Incremental growth charts. Am J Clin Nutr. 1980;33:2041-2052.
10. UNAIDS. AIDS epidemic update, December 2003. Available at: http:// www.unaids.org. Accessed February 10, 2004.
11. McKinney RE Jr., Robertson WR. Duke Pediatric AIDS Clinical Trials Unit: effect of human immunodeficiency virus infection on the growth of young children. J Pediatr. 1993;123:579-582.
12. Carey VJ, Yong FH, Frenkel LM, McKinney RE Jr. Pediatric AIDS prognosis using somatic growth velocity. AIDS. 1998;12:1361-1369.
13. Saez-Llorens X, Violari A, Deetz CO, et al. Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2003;22:216-224.